Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 2003

View Archived Issues

Sodium oxybate improves pain, fatigue and sleep patterns in fibromyalgia patients

PDE inhibitor counteracts sexual dysfunction associated with fluoxetine use

Use of oxymetholone to counter HIV wasting

VIP as a potential treatment for patients with primary pulmonary hypertension

First human data and further preclinical findings discussed for CAB-175

Solifenacin succinate safe and effective in patients with overactive bladder

Four series of inhibitors of IGF-1R, IR and IRR identified at Merck

Novel alpha7 nAChR agonists and their use described by P&U (Pfizer)

Pfizer presents new PDE9 inhibitors with utility in hypertension therapy

Novel series of NR2B-selective NMDA antagonists covered by Roche patent

Roche claims new retinoid agonists with utility in emphysema, cancer and dermatological disorders

Tau protein kinase inhibitors designed by Mitsubishi and Sanofi-Synthelabo scientists

Novel series of HIV integrase inhibitors presented by Italian researchers

Higher GI-related expenses for Fosamax patients versus Actonel patients

INS-37217 Intranasal fails to meet primary endpoint in perennial allergic rhinitis trial

Phase I trial of interferon enhancer EMZ-701 completed

CPMP contraindicates concomitant use of repaglinide and gemfibrozil

Advanced Life Sciences licenses ALS-499 from Argonne National Laboratory

Novartis Generics rebranded as Sandoz

Valentis licenses delivery technology to Juvaris

Patient enrollment begins in phase II trial of ThGRF in HIV-related lipodystrophy

Speedel acquires full rights to SPP-301 from Roche

EMEA hands down positive opinion on Humira

Ipsen acquires development rights to SJG-136 from Spirogen

Biovitrum and GSK to focus efforts on highly selective 5-HT2C receptor agonists

CeNeS divests three products, allocates profits

Wyeth and Takeda sign new partnership agreements

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...